Travere Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $263k | 34k | 7.71 |
| 2023-12-31 | $292k | 33k | 8.99 |
| 2023-09-30 | $857k | 96k | 8.94 |
| 2023-06-30 | $1.9M | 123k | 15.36 |
| 2022-12-31 | $68k | 3.2k | 21.03 |
| 2022-09-30 | $130k | 5.3k | 24.39 |
| 2022-06-30 | $103k | 4.3k | 24.13 |
| 2022-03-31 | $1.1M | 43k | 25.76 |
| 2021-12-31 | $1.9M | 60k | 31.25 |
| 2021-09-30 | $1.1M | 46k | 23.86 |
| 2021-06-30 | $3.1M | 211k | 14.59 |
| 2021-03-31 | $3.8M | 151k | 24.97 |
| 2020-12-31 | $3.1M | 112k | 27.24 |